Comparative Bioactivity Analysis for Off-the-Shelf and Culture-Rescued Umbilical Cord-Derived Mesenchymal Stem/Stromal Cells in a Xeno- and Serum-Free Culture System.

Minh Quang Nguyen, Hue T H Bui, Anh Nguyen Thi Tuyet, Trinh Thi Hong Nhung, Duc M Hoang, Nguyen Thanh Liem, Van T Hoang
Author Information
  1. Minh Quang Nguyen: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.
  2. Hue T H Bui: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam. ORCID
  3. Anh Nguyen Thi Tuyet: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.
  4. Trinh Thi Hong Nhung: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.
  5. Duc M Hoang: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.
  6. Nguyen Thanh Liem: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.
  7. Van T Hoang: Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), Vinmec Healthcare System, Hanoi, Vietnam.

Abstract

We recently reported a standardized xeno- and serum-free culture platform to isolate and expand umbilical cord-derived mesenchymal stem/stromal cells (UC-MSCs). Comparing populations from the same passage, cells that were cryopreserved and culture-rescued exhibited characteristics similar to those of their fresh counterparts, continuously cultured cells without interim cryopreservation. The culture rescue after thawing allowed for the cells to be fully recovered. However, since it would be more cost-effective and timesaving if cryopreserved cells can be used as an off-the-shelf product, we set out to compare the bioactivity of freshly thawed UC-MSCs versus culture-rescued UC-MSCs of the same batch that were recultured for an additional passage under our xeno- and serum-free protocol. UC-MSCs showed high viability in both the freshly thawed and the re-cultured group. Both populations displayed a similar proliferation capacity which is indicated by a comparable population doubling time and colony-forming ability. Both freshly thawed and culture-rescued UC-MSCs expressed the characteristic immunophenotype and were capable of differentiating into osteocytes, chondrocytes, and adipocytes. On the other hand, culture-rescued cells appeared to be more potent in immunosuppression than freshly thawed cells. In conclusion, freshly thawed and culture-rescued cell products share comparable bioactivity in cell growth and proliferation, immunophenotype, and differentiation potential. However, the culture-rescued cells that were allowed to grow for an additional passage appear to display a more favorable immunomodulatory potential when compared to their freshly thawed parent cells.

Keywords

References

  1. Cytotherapy. 2012 Feb;14(2):147-52 [PMID: 22029655]
  2. Curr Stem Cell Res Ther. 2013 Jan;8(1):60-72 [PMID: 23270628]
  3. Sci Rep. 2020 Mar 9;10(1):4290 [PMID: 32152403]
  4. Cell Tissue Bank. 2015 Jun;16(2):181-93 [PMID: 25117730]
  5. Front Cell Dev Biol. 2020 May 05;8:258 [PMID: 32478063]
  6. Stem Cells. 2014 Sep;32(9):2430-42 [PMID: 24805247]
  7. Int J Mol Med. 2017 Apr;39(4):775-782 [PMID: 28290609]
  8. Stem Cells Transl Med. 2019 Nov;8(11):1126-1134 [PMID: 31282113]
  9. Cell Stem Cell. 2018 Jun 01;22(6):824-833 [PMID: 29859173]
  10. J Transl Med. 2019 Nov 29;17(1):397 [PMID: 31783866]
  11. Stem Cells Transl Med. 2020 Jan;9(1):17-27 [PMID: 31804767]
  12. Stem Cells Int. 2019 Apr 9;2019:9628536 [PMID: 31093291]
  13. Gastroenterology. 2018 Apr;154(5):1334-1342.e4 [PMID: 29277560]
  14. Sci Rep. 2019 Dec 2;9(1):18078 [PMID: 31792313]
  15. Cytotherapy. 2021 Jan;23(1):88-99 [PMID: 33097415]
  16. Cytotherapy. 2015 Feb;17(2):186-98 [PMID: 25593077]
  17. Cytotherapy. 2017 Mar;19(3):360-370 [PMID: 28040463]
  18. PLoS One. 2014 Dec 01;9(12):e113615 [PMID: 25438145]
  19. Cell Rep. 2018 Feb 27;22(9):2504-2517 [PMID: 29490284]
  20. Stem Cell Res Ther. 2020 Dec 14;11(1):540 [PMID: 33317625]
  21. Biol Blood Marrow Transplant. 2020 May;26(5):845-854 [PMID: 32018062]
  22. Sci Adv. 2020 Jul 22;6(30):eaba6884 [PMID: 32832666]
  23. Lancet. 2016 Sep 24;388(10051):1281-90 [PMID: 27477896]
  24. Stem Cells Int. 2018 Apr 1;2018:8429042 [PMID: 29760736]
  25. NPJ Regen Med. 2019 Dec 2;4:22 [PMID: 31815001]
  26. J Transl Med. 2019 Aug 29;17(1):297 [PMID: 31464641]
  27. Cytotherapy. 2012 Jul;14(6):694-700 [PMID: 22519634]
  28. Sci Rep. 2016 May 23;6:26463 [PMID: 27212469]
  29. Front Immunol. 2019 Jul 16;10:1627 [PMID: 31379832]
  30. Front Immunol. 2019 Apr 02;10:619 [PMID: 31001253]

MeSH Term

Cell Culture Techniques
Cell Proliferation
Cell- and Tissue-Based Therapy
Cells, Cultured
Humans
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells
Umbilical Cord

Word Cloud

Created with Highcharts 10.0.0cellsculture-rescuedfreshlythawedUC-MSCscellmesenchymalpassagexeno-serum-freecultureumbilicalpopulationscryopreservedsimilarcryopreservationallowedHoweverbioactivityadditionalproliferationcomparableimmunophenotypepotentialrecentlyreportedstandardizedplatformisolateexpandcord-derivedstem/stromalComparingexhibitedcharacteristicsfreshcounterpartscontinuouslyculturedwithoutinterimrescuethawingfullyrecoveredsincecost-effectivetimesavingcanusedoff-the-shelfproductsetcompareversusbatchreculturedprotocolshowedhighviabilityre-culturedgroupdisplayedcapacityindicatedpopulationdoublingtimecolony-formingabilityexpressedcharacteristiccapabledifferentiatingosteocyteschondrocytesadipocyteshandappearedpotentimmunosuppressionconclusionproductssharegrowthdifferentiationgrowappeardisplayfavorableimmunomodulatorycomparedparentComparativeBioactivityAnalysisOff-the-ShelfCulture-RescuedUmbilicalCord-DerivedMesenchymalStem/StromalCellsXeno-Serum-FreeCultureSystemtherapyimmunomodulationstemstromalcord

Similar Articles

Cited By